To appear in Best of the Brokers, email your research to email@example.com
Numis has raised the bank’s rating to “hold” with a 274p target price. The analyst said the forecast reductions reflect potentially weak fourth quarter revenue from fixed income and currencies as well as deleveraging, but some of the uncertainty has already been baked into the share price.
UBS has given BG Group a “buy” rating with a price target of £14.00 after rating the firm as its top pick in the European oil and gas industry. However it appear to be the pick of a bad bunch as UBS said the sector has “an absence of strong stories and continued failure to meet targets”.
Panmure Gordan has retained a “sell” rating for the drugmaker, but has increased its target price from £31.00 to £32.00. Analysts said approval of the firm’s gout and diabetic drugs mitigate some of the risk from the company’s contracting revenue base.